Oral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T-lymphocyte responses in mice

Journal of Virology

Volumn 71, Issue 3, 1997, Pages 2303-2309

  Lagranderie, Micheline ^a   Balazuc, Anne Marie ^a   Gicquel, Brigitte ^a   Gheorghiu, Marina ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BCG VACCINATION; CYTOTOXIC T LYMPHOCYTE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INFECTION PREVENTION; LYMPHOID TISSUE; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE SUBPOPULATION;

EID: 0031051553     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.3.2303-2309.1997     Document Type: Article

References (47)

1. Aldovini, A., and R. Young. 1991. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature 351:479-482.
2. Amerongen, H. M., R. Weltzin, C. Farnet, P. Michetti, W. Haseltine, and M. Neutra. 1991. Transepithelial transport of HIV-1 by intestinal M cells: a mechanism for transmission of AIDS. J. Acquired Immune Defic. Syndr. 4:760-765.
3. Battegay, M., D. Kyburz, H. Hengartner, and R. M. Zinkernagel. 1993. Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells. Eur. J. Immunol. 23:3236-3241.
4. Benveniste, O., B. Vaslin, R. Le Grand, P. Fouchet, V. Omessa, F. Theodora, P. Fretier, P. Clayette, F. Boussin, and D. Dormont. 1996. Interleukin 1β, interleukin 6, tumor necrosis factor α, and interleukin 10 responses in peripheral blood mononuclcar cells of cynomolgus macaques during acute infection with SIV mac 251. AIDS Res. Hum. Retroviruses 12:241-250.
5. Chardes, T. D. Buzoni-Gatel, A. Lepage, F. Bernard, and D. Bout. 1994. Toxoplasma gondii oral infection induces specific cytotoxic CDS α/β+ Thy-1+ gut intraepithelial lymphocytes, lytic for parasite-infected enterocytes. J. Immunol. 153:4596-4603.
6. Czerkinsky, C., L. A. Nilsson, H. Nygren, Ö. Ouchtherlony, and A. Tarkowski. 1983. A solid phase enzyme linked immunospot (ELISPOT) assay for enumeration of specific antibody secreting cells. J. Immunol. Methods 65:109-121.
7. Daniel, M. D., F. Kirchoff, S. C. Czajak, P. K. Sehgal, and R. C. Desrosiers. 1992. Protective effect of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938-1941.
8. Dialynas, D. P., Z. S. Quan, K. A. Wall, A. Pierres, J. Quintans, M. R. Loker, M. Pierres, and F. W. Fitch. 1984. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1-5: similarity of L3T4 to human Leu3/T4 molecule. J. Immunol. 131:2445-2454.
9. Dittmer, U., T. Niblein, W. Bodemer, H. Petry, U. Sauermann, C. Stalh-Hennig, and G. Hunsmann. 1995. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus. Virology 212:392-397.
10. Fantini, J., N. Yahi, and J. C. Chermann. 1991. Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonie epithelial cells. Proc. Natl. Acad. Sci. USA 88:9297-9301.
11. Flores-Romo, L., K. B. Bacon, T. Estrada-Garcia, P. F. Life, J. P. Aubry, J.-Y. Bonnefoy, and A. Escobar-Gutiérrez. 1995. HIV and the colonie route of entry: effect of inflammatory cytokines on the binding of HIV-gp120 and T-cells to human enterocytes. Immunol. Lett. 47:139-140.
12. Füst, G., F. D. Toth, J. Kiss, E. Ujhelyi, I. Nagy, and D. Banhegyi. 1994. Neutralizing and enhancing antibodies measured in complement-restored serum samples from HIV-1-infected individuals correlate with immunosuppression and disease. AIDS 8:603-609.
13. Gallimore, A., M. Granage, N. Cook, N. Almond, J. Bootman, E. Rud, P. Silvera, M. Dennis, T. Corcoran, J. Stott, A. McMichael, and F. Gotch. 1995. Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nat. Med. 1:1167-1171.
14. Gheorghiu, M. 1994. BCG-induced mucosal immune responses. Int. Immunopharmacol. 16:435-444.
15. Gheorghiu, M., P. H. Lagrange, and C. Fillastre. 1988. The stability and immunogenicity of a dispersed-grown freeze dried Pasteur BCG vaccine. J. Biol. Stand. 16:15-26.
16. Gheorghiu, M., M. R. R. Lagranderie, B. M. E. Gicquel, and C. D. Leclerc. 1994. Mycobacterium bovis BCG priming induces a strong potentiation of the antibody response induced by BCG expressing a foreign antigen. Infect. Immun. 62:4287-4295.
17. Gheorghiu, M., M. Lagranderie, A. M. Balazuc, and B. Gicquel. 1995. Mucosal induced immune responses after oral BCG vaccination. Clin. Immunol. Immunopathol. 76:547.
18. Goodman, T., and L. Lefrancois. 1989. Intraepithelial lymphocytes. Anatomical site, not T cell receptor form, dictates phenotype and function. J. Exp. Med. 170:1569-1581.
19. Guy-Grand, D., C. Griscelli, and P. Vassali. 1978. The mouse gut T lymphocyte, a novel type of T cell. Nature, origin and traffic in mice in normal and graft-versus-host conditions. J. Exp. Med. 148:1661-1677.
20. Guy-Grand, D., M. Malassis-Seris, C. Briottet, and P. Vassali. 1991. Cytotoxic differentiation of mouse gut thymus-dependent and independent intra-epithelial T lymphocytes is induced locally: correlation between functional assays, presence of perform and granzyme transcripts and cytoplasmic granules. J. Exp. Med. 173:1549-1552.
21. Guy-Grand, D., and P. Vassali. 1993. Gut intraepithelial T-lymphocytes. Curr. Opin. Immunol. 5:247-252.
22. Honda, M., K. Matsuo, T. Nakasone, Y. Okamoto, H. Yoshizaki, K. Kitamura, W. Sugiura, K. Watanabe, Y. Fukushima, S. Haga, Y. Katsura, H. Tasaka, K. Komuro, T. Yamada, T. Asano, A. Yamazaki, and S. Yamazaki. 1995. Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guerin vector candidate vaccine for human immunodeficiency virus type 1 in small animals. Proc. Natl. Acad. Sci. USA 92:10693-10697.
23. Hussain, L. A., C. Kelly, A. Rodin, M. Jourdan, and T. Lehner. 1995. Investigation of the complement receptor 3 (CD11b/CD18) in human rectal epithelium. Clin. Exp. Immunol. 102:384-388.
24. Kalyanaraman, V. S., C. D. Cabradilla, J. P. Getchell, R. Narayanan, E. H. Braff, J. C. Chermann, F. Barre-Sinoussi, L. Montagnier, T. J. Spira, J. Kaplan, D. Fishbein, H. W. Jaffe, J. W. Curran, and D. P. Francis. 1984. Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS. Science 225:321-323.
25. Kameoka, M., Y. Nishino, K. Matsuo, N. Ohara, T. Kimura, A. Yamazaki, T. Yamada, and K. Ikuta. 1994. Cytotoxic T lymphocyte response in mice induced by a recombinant BCG vaccination which produces an extracellular a antigen that fused with the human immunodeficiency virus type 1 envelope immunodominant domain in the V3 loop. Vaccine 12:153-158.
26. Klavinskis, L., L. Bergmeier, L. Gao, E. Mitchell, R. Ward, G. Layton, R. Brookes, N. Meyers, and T. Lehner. 1996. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes. J. Immunol. 157:2521-2527.
27. Lagranderie, M., A. Murray, B. Gicquel, C. Leclerc, and M. Gheorghiu. 1993. Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen. Vaccine 11:1283-1290.
28. Lagranderie, M. R. R., A. M. Balazuc, E. Deriaud, C. Leclerc, and M. Gheorghiu. 1996. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect. Immun. 64:1-9.
29. Lehner, T., R. Brookes, C. Panagiotidi, L. Tao, L. S. Klavinskis, J. Walker, P. Walker, R. Ward, L. Hussain, A. J. H. Gearing, S. E. Adams, and L. A. Bergmeier. 1993. T- and B-cell functions and epitope expression in nonhuman primates immunized with simian immunodeficiency virus antigen by the rectal route. Proc. Natl. Acad. Sci. USA 90:8638-8642.
30. Lehner, T., and C. J. Miller. 1996. Rectal and genital immunization with SIV/HIV, p. 357-371. In H. Kiyono, P. Ogra, and J. McGhee (ed.), Mucosal vaccines. Academic Press, Inc., New York, N.Y.
31. Letvin, N. L., M. D. Daniel, P. K. Sehgal, R. C. Desrosiers, R. D. Hunt, L. M. Waldron, J. J. Mackey, D. K. Schmidt, L. V. Chalifoux, and N. W. King. 1985. Induction of AIDS-like disease in macaque monkey with T-cell tropic retrovirus STLV-III. Science 230:71-73.
32. Levy, J. A. 1993. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57:183-289.
33. London, S. D., D. H. Rubin, and J. J. Cebra. 1987. Gut mucosal immunization with reovirus serotype 1/L stimulates virus-specific cytotoxic T cell precursors as well as IgA memory cells in Peyer's patches. J. Exp. Med. 165:830-847.
34. McGhee, J. R., J. Mestecky, M. T. Dertzbaugh, J. H. Eldridge, M. Hirosawa, and H. Kiyono. 1992. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10:75-88.
35. Mega, J., J. R. McGhee, and H. Kiyono. 1992. Cytokine and Ig-producing cells in mucosal effector tissues: analysis of IL-5 and IFN-g-producing T cells, T cell receptor expression, and IgA plasma cells from mouse salivary gland-associated tissues. J. Immunol. 148:2030-2039.
36. Neutra, M., and J. P. Kraehenbuhl. 1996. Antigen uptake by M cells for effective mucosal vaccines, p. 41-55. In H. Kiyono, P. Ogra, and J. R. McGhee (ed.), Mucosal vaccines. Academic Press, Inc., New York, N.Y.
37. Offit, P. A., S. L. Cunningham, and K. I. Dudzik. 1991. Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection. J. Virol. 65:1318-1324.
38. Pierres, M., C. Goridis, and P. Goldstein. 1982. Inhibition of murine T cell-mediated cytolysis and T cell proliferation by a rat monoclonal antibody immunoprecipitating two lymphoid cell surface polypeptides of 94000 and 180000 molecular weight. Eur. J. Immunol. 12:60-65.
39. Sabin, A. B. 1992. Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal portal of entry. Proc. Natl. Acad. Sci. USA 89:8852-8855.
40. Sarngadharan, M. G., M. Popovic, L. Bruch, J. Schupbach, and R. C. Gallo. 1984. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science 224:506-508.
41. Taguchi, T., J. R. McGhee, R. L. Coffman, K. W. Beagley, J. H. Eldrige, K. Takatsu, and H. Kiyono. 1990. Detection of individual mouse splenic T cells producing IFNγ and IL5 using the enzyme linked immunospot (ELISPOT) assay. J. Immunol. Methods 128:65-73.
42. Tsubota, H., C. I. Watkins, C. Morimoto, and N. L. Letvin. 1989. A cytotoxic T-lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J. Exp. Med. 169:1421-1424.
43. Van Deinse, F. 1948. Enquête sur la frequence des adénites suppurées consécutives à la vaccination au BCG par scarifications cutanées ou par voie buccale, p. 89-91. In Premier Congrès International du BCG 1948. Institut Pasteur, Paris, France.
44. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563-1566.
45. Winter, N., M. Lagranderie, J. Rauzier, J. Timm, C. Leclerc, B. Guy, M. P. Kieny, M. Gheorghiu, and B. Gicquel. 1991. Expression of a heterologous gene in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein. Gene 109:47-54.
46. mac251 nef gene induce proliferative and CTL responses against nef synthetic peptides in mice. Vaccine 13:471-478.
47. Yasumoti, Y., S. Koenig, R. M. Woods, J. Madsen, N. M. Wassef, C. R. Alving, H. J. Klein, T. E. Nolan, L. J. Boots, J. A. Kessler, E. A. Emini, A. J. Conley, and N. L. Letvin. 1995. A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous cell-free simian immunodeficiency virus challenge. J. Virol. 69:2279-2284.